The Advance Market Commitment scheme, formulated by the GAVI Alliance, aims to provide more vaccines to the developing world by fixing their price over a 10-year period. Is it going to deliver, what will be the result, and how did global health institutions and the big pharmaceutical companies manage to agree on such a deal?
Kids in developing countries need vaccines, but will the world's wealthy financial markets really help to deliver them? A deal brokered by former British Prime Minister Gordon Brown has so far raised nearly $2 billion for just that purpose. It's called the International Finance Facility for Immunisation (IFFIm), and author Aminatta Forna wants to know how it works.
At TEDxChange, Melinda Gates makes a provocative case for nonprofits taking a cue from corporations such as Coca-Cola, whose plugged-in, global network of marketers and distributors ensures that every remote village wants—and can get—a Coke. Why shouldn't this work for condoms, sanitation, vaccinations too?
Alleviating poverty is more guesswork than science, and lack of data on aid's impact raises questions about how to provide it. But Clark Medal-winner Esther Duflo says it's possible to know which development efforts help and which hurt—by testing solutions with randomized trials.